The GLP-1 Black Market Threatens U.S. American Patients and Patents
A black market in weight-loss drugs is flourishing in plain sight.
Rogue pharmacies and telehealth firms are flooding the United States with unauthorized knock-offs of semaglutide, tirzepatide, and other glucagon-like peptide-1 drugs.
Read more at Newsmax© 2025 Newsmax. All rights reserved.